Finally, although both S10010-18 and S10020-28 are NPPEs eluted from HLA-A2.1 molecules, present results show that A2.1-negative T1D patients also respond against these peptide epitopes. Here, IGKV2-26 is linked to type 1 diabetes mellitus.